These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 17598435
1. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report]. Milejski P, Orzechowska-Juzwenko K, Niewiński P, Hurkacz M, Czarnik-Matusewicz H, Leszek J, Rudzik J, Grotthus B. Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435 [Abstract] [Full Text] [Related]
2. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease]. Milejski P, Orzechowska-Juzwenko K, Kamienowski J, Horoch E, Niewiński P, Hurkacz M, Rzemisławska Z. Neurol Neurochir Pol; 1999; 33(5):1015-24. PubMed ID: 10672554 [Abstract] [Full Text] [Related]
8. Acetylator phenotype in patients with allergic diseases and its clinical significance. Orzechowska-Juzwenko K, Milejski P, Patkowski J, Nittner-Marszalska M, Malolepszy J. Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):420-5. PubMed ID: 2258251 [Abstract] [Full Text] [Related]
9. [Oxidation phenotype as a risk factor for development of allergic diseases]. Niewiński P, Orzechowska-Juzwenko K, Patkowski J, Wolańczyk-Medrala A, Nittner-Marszalska M, Rzemisławska Z. Pol Arch Med Wewn; 1999 Jan; 101(1):23-7. PubMed ID: 10592724 [Abstract] [Full Text] [Related]
10. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease]. Yoshino H, Hattori Y, Imai H, Narabayashi H, Chiba K. Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787 [Abstract] [Full Text] [Related]
17. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk? Peters JH, Gordon GR, Lin E, Green CE, Tyson CA. Anticancer Res; 1990 Jun; 10(1):225-9. PubMed ID: 2334132 [Abstract] [Full Text] [Related]
18. Oxidative phenotype status in related subjects. Rychlik-Sych M, Łyczba M, Skretkowicz J. Acta Pol Pharm; 2008 Jun; 65(1):165-8. PubMed ID: 18536192 [Abstract] [Full Text] [Related]
19. [Acetylation phenotype in Graves' disease]. Górnik W, Syrenicz A, Gawrońska-Szklarz B, Wójcicki J. Pol Tyg Lek; 2008 Jun; 44(32-33):743-5. PubMed ID: 2641798 [Abstract] [Full Text] [Related]